June 22, 2022
Via: PharmaphorumOne of these – dubbed V116 – is a cocktail of 21 Streptococcus pneumoniae serotypes designed to have the most benefit in adult populations, and it has just cleared a phase 1/2 trial as it embarks on a phase 3 […]
June 22, 2022
Via: PharmaphorumIn a global economy, across a number of industries, low-margin products are often manufactured in countries where labour is cheap. The pharmaceutical industry is no different, with India and China becoming two of the leading manufacturers and exporters of generic […]
Cell and Gene Therapy, Industry
June 21, 2022
Via: Biopharma DiveVertex’s latest treatment for cystic fibrosis is a “triple combination” drug called Trikafta, which like others from Vertex boosts the activity of a protein that’s defective in people with the disease. It has quickly become a go-to treatment, entrenching Vertex’s […]
June 21, 2022
Via: Biopharm InternationalThe European Medicines Agency (EMA) has begun a rolling review of the Spikevax vaccine that has been adapted to protect against two variant strains of SARS-CoV-2, the agency announced on June 17, 2022. The review will focus on non-clinical laboratory […]
June 20, 2022
Via: Drugs.comAfter a final sign-off on Saturday from the head of the U.S. Centers for Disease Control and Prevention, COVID-19 vaccines for children younger than 5 have finally become a reality. “This expands eligibility for vaccination to nearly 20 million additional […]
June 16, 2022
Via: PharmaphorumThe Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to zero in favour of both vaccines in this age group, in light of rising rates of hospitalisations and deaths that have been seen in the very young during […]
Clinical Trials, Research and Development
June 16, 2022
Via: PharmaphorumThe result isn’t a big surprise – Roche terminated two phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer’s in early 2019 after interim analyses found it would be futile to continue – but is another […]
Industry, Manufacturing, Research and Development, Vaccines
June 15, 2022
Via: PMLiVEWhen vaccines became available earlier in the COVID-19 pandemic, countries vied for supply contracts. However, as the need for vaccines begins to slow in Europe, some countries want to amend their contracts to reduce spending and to prevent receiving more […]
June 14, 2022
Via: Drugs.comThe first pill to treat adults with severe alopecia was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot, the agency […]
June 13, 2022
Via: Biopharma DiveCOVID-19 vaccines have been authorized in the U.S. for a year and a half, with the FDA progressively expanding their clearances to cover broader and broader swathes of the population. Yet they are still unavailable to the youngest children, who […]
Manufacturing, Research and Development
June 9, 2022
Via: Biopharma DiveWhile recent years have seen scientists make major advances in cutting-edge treatments such as gene and cell therapies, manufacturing remains a significant hurdle. The complex, multi-step processes required are beyond the capabilities of a traditional pharmaceutical plant. That’s where Resilience […]
June 8, 2022
Via: Drugs.comA U.S. Food and Drug Administration vaccine advisory panel on Tuesday recommended that Novavax’s COVID-19 shots be added to the vaccine arsenal that Americans have at their disposal. Twenty-one panel members voted to approve the vaccine, while one person abstained. […]
May 31, 2022
June 16, 2022
Copyright © 2022. All rights reserved
